Values Analyst Adelphi at Adelphi Values PROVE (2024-09 – Present)
- Collaborated directly with pharmaceutical clients to develop evidence generation strategies and health economic frameworks for global market access.
- Managed multiple client projects simultaneously, coordinating cross-functional teams and ensuring delivery within tight regulatory timelines
- Developed client-facing presentations, translating complex analytical findings on economic modelling for neurological interventions into strategic recommendations for C-suite executives and HEOR managers in a global pharmaceutical company. The outcome was a comprehensive, technical health economic report detailing the modelling and HTA considerations for sponsors developing interventions in neuroscience, and the potential challenges they may face.
National Policy and Advocacy Director at Students for Global Health (2023-09 – 2024-06)
- Conducting policy analysis of current issues in global health, such as access to treatments across low and middle-income countries, and the absence of targeting primary care infrastructure in international aid programs.
- Organised a Parliamentary Education Day event, in collaboration with the Foreign Commonwealth and Development Office, to educate young members of the organisation about UK strategies to improve global health initiatives for women.
PharmaQuant Intern at PharmaQuant (2023-07 – 2023-07)
- Health Economics and Outcomes Research (HEOR) industrial experience on "Duchenne Muscular Dystrophy (DMD)".
- Exposed to a basic understanding of the HEOR domain, the NICE regulatory process on rare diseases, and economic evaluation.
- Conducted a rapid review of "Economic and disease burden on Duchenne Muscular Dystrophy" in which I conducted a systematic search in PubMed, Clinical trial registries, and NICE, followed by data synthesis on disease burden, unmet needs, drug-related policies, and scales used for measuring the outcomes.
Team Researcher at Bentham Brooks Institute International Policy Think-Tank in London (2022-10 – 2023-04)
- I collaborated with a small team in conducting political research on the impact of civil war on economic fragility in Africa.
- Weekly presentations on new findings in the scholarship, and how to conduct quantitative analysis. Our current methods have included statistical regression analysis using R-code, and descriptive statistical analysis to identify potential confounders to our hypothesis.
Internship at Grayling Public Affairs (2022-07 – 2022-08)
- Communicated with political stakeholders in the Greater Manchester region to inform them about the forecasted growth and opportunities for development in Transport for Greater Manchester and telecommunications
- Engaged in a research project with AbbVie, a pharmaceutical research and development company specialising in drug delivery. As my placement occurred towards the tail-end of the project, my role included drafting a project impact completion brief for Grayling.
- Outcome: Abbvie positioned itself as a key stakeholder in healthy aging and sustainability by establishing an expert group.
commodities analyst at Investment Banking Society (2021-10 – 2022-05)
- Weekly insights into market events affecting the value of global commodities prices
- Exclusive workshop and panel experience with leading industry sectors, learning about the skills and processes needed to be successful in the financial industry
- Symposium presentation on an ESG initiative demonstrated within the commodities sector.
